Chargement en cours...
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism
The development of antitumor chemotherapy drugs remains a key goal for oncologists, and natural products provide a vast resource for anti-cancer drug discovery. In the current study, we found that the flavonoid dihydromyricetin (DHM) exhibited antitumor activity against liver cancer cells, including...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3982169/ https://ncbi.nlm.nih.gov/pubmed/24717393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep04628 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|